Government Reviews the Drug Pricing Formula
The proposed changes also revise hardship policy rules and aim to make medicines more affordable.
The government is reviewing Pakistan's drug pricing formula to improve transparency, strengthen regulatory oversight and make medicines more affordable. The drug pricing review is still a review, so the formula has not been replaced.
The proposed changes include tighter checks on price increases, revised hardship policy rules and independent verification of international reference prices. Each of those steps is part of the proposal.
What the drug pricing review would change
Tighter checks would apply to price increases. Hardship policy rules would be revised. International reference prices would be checked independently, rather than taken only from the companies' own figures. The stated aims are transparency, stronger oversight and more affordable medicines.
Our verdict
This is a review of the formula, with proposed checks on price rises, a revised hardship policy and independent verification of international reference prices. It is aimed at transparency, oversight and affordability, and it is not a completed price cut.
Follow for more updates.
Frequently asked questions
What is being reviewed?
Pakistan's drug pricing formula.
Why is it being reviewed?
To improve transparency, strengthen regulatory oversight and make medicines more affordable.
What changes are proposed?
Tighter checks on price increases, revised hardship policy rules and independent verification of international reference prices.
Have the new rules taken effect?
No. The update describes a review and proposed changes.
- #Enable Pakistan 22
- #drug pricing
- #Pakistan drug pricing formula
- #medicine prices Pakistan
- #hardship policy drugs
- #drug price oversight
Written by
Enable PakistanGet stories like this in your inbox
The day's top stories, every morning. Free, unsubscribe any time.
